Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

A synthetic optogenetic transcription device enhances blood-glucose homeostasis in mice.

Ye H, Daoud-El Baba M, Peng RW, Fussenegger M.

Science. 2011 Jun 24;332(6037):1565-8. doi: 10.1126/science.1203535.

2.

Physiology. Synthetic physiology.

Chow BY, Boyden ES.

Science. 2011 Jun 24;332(6037):1508-9. doi: 10.1126/science.1208555. No abstract available.

3.

Optogenetic therapeutic cell implants.

Ausländer D, Fussenegger M.

Gastroenterology. 2012 Aug;143(2):301-6. doi: 10.1053/j.gastro.2012.06.019. Epub 2012 Jun 18. Review. No abstract available.

PMID:
22721803
4.

Ectopic expression of glucagon-like peptide 1 for gene therapy of type II diabetes.

Parsons GB, Souza DW, Wu H, Yu D, Wadsworth SG, Gregory RJ, Armentano D.

Gene Ther. 2007 Jan;14(1):38-48. Epub 2006 Aug 24.

PMID:
16929351
5.

Distinct mechanisms of glucose lowering by specific agonists for peroxisomal proliferator activated receptor gamma and retinoic acid X receptors.

Li X, Hansen PA, Xi L, Chandraratna RA, Burant CF.

J Biol Chem. 2005 Nov 18;280(46):38317-27. Epub 2005 Sep 22.

6.

Mammalian cell lines engineered to identify inhibitors of specific signal transduction pathways.

Jones RE, Defeo-Jones D, McAvoy EM, Vuocolo GA, Wegrzyn RJ, Haskell KM, Oliff A.

Oncogene. 1991 May;6(5):745-51.

PMID:
1711189
7.

Engineered glucagon-like peptide-1-producing hepatocytes lower plasma glucose levels in mice.

Riedel MJ, Lee CW, Kieffer TJ.

Am J Physiol Endocrinol Metab. 2009 Apr;296(4):E936-44. doi: 10.1152/ajpendo.90768.2008. Epub 2009 Feb 3.

8.

Emerging biomedical applications of synthetic biology.

Weber W, Fussenegger M.

Nat Rev Genet. 2011 Nov 29;13(1):21-35. doi: 10.1038/nrg3094. Review.

PMID:
22124480
9.

A synthetic metabolite-based mammalian inter-cell signaling system.

Weber W, Schuetz M, Dénervaud N, Fussenegger M.

Mol Biosyst. 2009 Jul;5(7):757-63. doi: 10.1039/b902070p. Epub 2009 Apr 28.

PMID:
19562115
10.

Dual specificity mitogen-activated protein (MAP) kinase phosphatase-4 plays a potential role in insulin resistance.

Xu H, Dembski M, Yang Q, Yang D, Moriarty A, Tayber O, Chen H, Kapeller R, Tartaglia LA.

J Biol Chem. 2003 Aug 8;278(32):30187-92. Epub 2003 May 30.

11.

Gene therapy of diabetes using a novel GLP-1/IgG1-Fc fusion construct normalizes glucose levels in db/db mice.

Kumar M, Hunag Y, Glinka Y, Prud'homme GJ, Wang Q.

Gene Ther. 2007 Jan;14(2):162-72. Epub 2006 Aug 31.

PMID:
16943856
12.

Vitamin H-regulated transgene expression in mammalian cells.

Weber W, Bacchus W, Daoud-El Baba M, Fussenegger M.

Nucleic Acids Res. 2007;35(17):e116. Epub 2007 Sep 7.

13.

Controlling transgene expression in subcutaneous implants using a skin lotion containing the apple metabolite phloretin.

Gitzinger M, Kemmer C, El-Baba MD, Weber W, Fussenegger M.

Proc Natl Acad Sci U S A. 2009 Jun 30;106(26):10638-43. doi: 10.1073/pnas.0901501106. Epub 2009 Jun 22.

14.

Semi-synthetic mammalian gene regulatory networks.

Kramer BP, Fischer M, Fussenegger M.

Metab Eng. 2005 Jul;7(4):241-50.

PMID:
16140238
15.

Gas-inducible transgene expression in mammalian cells and mice.

Weber W, Rimann M, Spielmann M, Keller B, Daoud-El Baba M, Aubel D, Weber CC, Fussenegger M.

Nat Biotechnol. 2004 Nov;22(11):1440-4. Epub 2004 Oct 17.

PMID:
15502819
16.

A novel mammalian expression system derived from components coordinating nicotine degradation in arthrobacter nicotinovorans pAO1.

Malphettes L, Weber CC, El-Baba MD, Schoenmakers RG, Aubel D, Weber W, Fussenegger M.

Nucleic Acids Res. 2005 Jul 7;33(12):e107.

17.

Streptomyces-derived quorum-sensing systems engineered for adjustable transgene expression in mammalian cells and mice.

Weber W, Schoenmakers R, Spielmann M, El-Baba MD, Folcher M, Keller B, Weber CC, Link N, van de Wetering P, Heinzen C, Jolivet B, Séquin U, Aubel D, Thompson CJ, Fussenegger M.

Nucleic Acids Res. 2003 Jul 15;31(14):e71.

18.

Macrolide-based transgene control in mammalian cells and mice.

Weber W, Fux C, Daoud-el Baba M, Keller B, Weber CC, Kramer BP, Heinzen C, Aubel D, Bailey JE, Fussenegger M.

Nat Biotechnol. 2002 Sep;20(9):901-7. Epub 2002 Aug 19.

PMID:
12205509
19.

The cAMP-HMGA1-RBP4 system: a novel biochemical pathway for modulating glucose homeostasis.

Chiefari E, Paonessa F, Iiritano S, Le Pera I, Palmieri D, Brunetti G, Lupo A, Colantuoni V, Foti D, Gulletta E, De Sarro G, Fusco A, Brunetti A.

BMC Biol. 2009 May 21;7:24. doi: 10.1186/1741-7007-7-24.

20.

Adenoviral vector-mediated glucagon-like peptide 1 gene therapy improves glucose homeostasis in Zucker diabetic fatty rats.

Lee Y, Kwon MK, Kang ES, Park YM, Choi SH, Ahn CW, Kim KS, Park CW, Cha BS, Kim SW, Sung JK, Lee EJ, Lee HC.

J Gene Med. 2008 Mar;10(3):260-8.

PMID:
18085721
Items per page

Supplemental Content

Write to the Help Desk